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Welcome to
The National Network of Libraries of Medicine
Substance Use Disorder Webinar Series
Harm Reduction, Medication Assisted Treatment and Considering Comorbid Disorders When Deciding Treatment 
Amy Harrington, MD
Assistant Professor of Psychiatry, University of Massachusetts
Medical Director for Acute Addiction Continuum, Community Healthlink, Worcester, MA
This Webinar is being recorded. Below is the URL to view the captions for this event:
http://livewrite-ncc.appspot.com/attend?event=citweb2
To Connect to Webinar Audio
1. To receive a call back, provide your phone number when you join the event, or call the number below and enter the access code.
2. Access Code 625 369 993
3. Call-in toll number (US/Canada) 1-650-479-3208
About Your Host: 
Susan Halpin
susan.halpin@umassmed.edu
New England Region, Education & Outreach Coordinator
University of Massachusetts Medical School 
Worcester, Massachusetts
About Your Instructor: 
Amy Harrington, MD
Assistant Professor of Psychiatry, University of Massachusetts
Medical Director for Acute Addiction Continuum, Community Healthlink, Worcester, MA
This webinar is being recorded.
Presentation slides and class materials will be available with the recording after 
the webinar.
About the National Library of Medicine
The National Library of Medicine (NLM) is the world’s largest medical library. The physical library is located on the 
National Institutes of Health campus in Bethesda, MD. NLM has made all of its resources digital. NLM funds 8 regional 
medical library programs nationwide. All resources are free and available to everyone. 
Link to National Library of Medicine https://www.nlm.nih.gov/
About the National Network of Libraries of Medicine
The University of Massachusetts Medical School Library serves as the New England Regional Medical Library, essentially a partner, for a network of health 
science libraries, public libraries, and special libraries located in New England called the National Network of Libraries of Medicine, New England Region, 
NNLM NER for short.  There are 7 other regions across the country that are part of this nationwide network. NNLM works to advance the progress of medicine 
and improve public health by providing equal access to biomedical information. We are funded by the NIH. Everything we offer is free. Take a look at the NER 
website - https://nnlm.gov/ner/
What are the Free Resources Offered by NNLM NER to Network Members?
Digital resources for Health Literacy, Healthy Communities, HealthIT, Knowledge Management, the Healthcare Workforce, 
Focused health information outreach for specific geographic areas 
Free professional development and training, promotional items and grant funding opportunities
What kind of Training is Offered by NNLM?
Professional medical librarians provide training on:
PubMed, MedlinePlus, TOXNET, PHPartners.org, Clinical Trials, Health Literacy, Complementary & Alternative Medicine, Environmental Health, Grant & 
Proposal Writing, Public Health, Senior Health
There are many professional development opportunities that network members can take advantage of in the form of webinars. Click on the professional 
development link https://nnlm.gov/professional-development
Customized programs highlighting the NLM resources for staff meetings, conferences and the public is also part of the training we provide.
Other Webinars in the Series
Link to register for the other webinars: 
https://nnlm.gov/classes/substance-use-disorders-webinar-series-alleviating-stigma-treatment-
strategies-community
Individualized Treatment and Understanding the Non-pharmacologic Components that are Part of 
Recovery
January 9, 2018 10-11AM
Dr. Gerardo Gonzalez, MD, Director of the Division of Addiction Psychiatry and Associate Professor in Psychiatry, Medical Director, Washburn House, Worcester, MA
Lindsey Silva, RN, MSN, Director of Quality and Compliance, Washburn House, Worcester, MA
Learn about the non-pharmacologic components of recovery. When developing individualized treatment plans, what factors are considered? The Medical Director 
and the Director of Quality and Compliance for Washburn House, a new treatment facility in Worcester, Massachusetts, will share their stories of starting a new 
treatment facility, and the challenges of putting evidence-based practices into practical use.
Learning Objectives: Individualized Treatment and Understanding the non-pharmacologic Components that are Part of Recovery
Understand the rationale and treatment options for managed withdrawal of a patient with opioid use disorder
Understand the rationale and treatment options for Medication Assisted Treatment in a patient with opioid use disorder
Understand the non-pharmacologic components that are part of recovery
Treating Opioid Use Disorder 
and Co-Occurring Disorders
Amy L. Harrington, MD, FAPA
Assistant Professor, Psychiatry, UMass Medical School
Medical Director, Acute Addiction Continuum, Community Healthlink
Disclosures
• No financial disclosures
• I have attempted to use generic names for medications whenever 
possible.  Any use of the brand names Suboxone or Vivitrol is because 
these are the terms by which patients and the community usually 
refer to these medications, and are not an endorsement of a specific 
brand.


Learning 
Objectives
Describe the philosophy of harm reduction as 
it relates to substance use disorders.Describe
List four harm reduction strategies used to 
minimize secondary harm from opioid use.List
Explain how comorbid disorders can affect 
substance use treatment.Explain
How did we get here?
• In the 90’s and 2000’s, there was a push to treat pain more 
aggressively.
• There was also a misconception that people who were prescribed 
opiates for medical reasons were at low risk of becoming dependent 
on them and developing behaviors associated with addiction.
• As prescriptions for opiates increased, so did admissions for 
treatment of opiate use disorder and deaths from opiate overdose

CDC, MMWR, November 4, 2011 / 60(43);1487-1492
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Harm Reduction
• Strategies for safer use
• Reduce negative consequences
• Meet the consumer “where they’re at”
Bystander-administered 
intranasal naloxone
• In areas where there is high-implementation, 
there are lower rates of death from opiate 
overdose than in areas with low-
implementation
• No significant difference in rates of overdose, 
any outcome
Syringe Exchange Programs
• Provide free sterile syringes in exchange for used ones
• Also provide supplies like sterile water for diluting opiates for 
injection and alcohol pads to sterilize the injection site.
• About a third have on-site medical care and vaccination for 
Hepatitis A and B
• More than half offer testing for Hepatitis C and HIV
• SEP’s can refer people to services like detoxification and other 
treatment
Supervised Injection Facilities
Supervised Injection Facilities
• “shooting galleries” already in Australia, Canada, Europe
• Sydney Medically Supervised Injecting Facility, 2001-present
• Decreased rates of injecting in public places
• No change in overdose rates, but no fatal overdoses at the facility
• Estimate between 4 and 25 lives saved annually
• No measurable impact on infectious disease transmission
• No change in crime rate or “honey-pot effect”
• Facility placed in area where injection drug use was already high
Supervised injection facilities
Moving on from harm reduction to treatment….
Strategies used 
in treatment of 
opioid use 
disorders
Acute 
detoxification
Residential
Out-patient 
therapy
Peer support, 
including 12-
Step
Medication

Life on a 
methadone clinic
• -full agonist at the mu-opiate 
receptor
• -mean half-life of 22 hours
• -have to go to the clinic daily
• -hard to get take-homes
• -drug-dealers hang out at 
methadone clinics
Suboxone 101….
-Suboxone has a 
“blocker” so if you 
take other opiates, 
there won’t be any 
effect.
The more advanced answer…
Buprenorphine binds more 
strongly to the mu opiate 
receptor than morphine, 
methadone and other full 
agonists.
If you take buprenorphine, 
a partial agonist, when 
there are full agonists in 
your system, you will feel 
like you are going into 
withdrawal
Naloxone, the blocker in 
Suboxone, really only goes 
into effect if someone 
shoots or snorts the pills 
• Many people prefer buprenorphine (Suboxone) 
to methadone for lifestyle reasons 
• Office-based, so see a doctor in a private office
• Can get a month’s worth of medication at a time
• Also, the opiate effects of buprenorphine level 
off, so less of a nod, which people often prefer
Naltrexone
What about Co-Occurring Disorders?
According to NESARC (2004)…
• Treatment seekers with alcohol use do
• 40% mood
• 33% anxiety
• Treatment seekers with drug use do
• 60% mood
• 42% anxiety
Results from my QI project:
Purpose to increase access to psych care for patients 
admitted to CHL addiction continuum with COD
Passages 
2014
Passages
2015
Passages
2016
Met criteria for 
COD
48/77
68.3%
22/33
66.7%
26/40
65%
Seen by psych at some point 
during admission
25/48
52.1%
7/22
31.8%
18/26
69.2%
Had appointment in OPD after 
discharge
11/48
22.9%
4/22
18.2%
10/26
38.5%
SAMHSA.  (2006)  Results from the 2005 National Survey on Drug Use and Health: National findings.  Rockville, 
MD.
Past year treatment for adults with COD 
Treatment for both (8.5%)
Substance use only (4.1%)
Mental health only (34.3%)
No treatment at all (53.0%)
Effects of substance use on course of 
psychiatric illness
• Decreased adherence with meds
• Increased hospitalization
• Shorter but more frequent stays
• Risk of victimization
• Increased suicidal ideation and completion
• Higher rates of side effects from medications

Sequential
Treat addiction Treat psychiatric 
issues
Parallel
Treat addiction
Treat 
psychiatric 
issues
Integrated
together
Treat 
psychiatric 
issues
and
Treat 
addiction
Types of Therapy
• Relapse Prevention
• Motivational Interviewing
• Cognitive Behavioral Therapy
• Contingency Management
• 12-step groups
• 12-step facilitation therapy
Argument not to treat with medication
• Depression/anxiety/psychosis could be caused alcohol or drug use, so 
wait and see if the symptoms go away with abstinence
• In the past, the medications had a much different side effect profile
• In my own personal experience, the social factors can impact 
adherence and the success of treatment.
My personal 
approach….
• Research suggests no reason to delay treating 
COD
• For patients with a history, restart meds ASAP due 
to long time before effective
• Address social determinants
• Connect with substance use treatment, including 
counseling or residential program
• Focus on treatment engagement, symptom relief
• Try to finds medications that are “two birds, one 
stone” like topiramate, naltrexone, etc.
Conclusions
• Harm reduction strategies can reduce harm caused by drug use and 
can help engage people with addiction with the health care system.
• Medications like methadone, buprenorphine and naltrexone give the 
brain a chance to heal the connections that allow for better 
communication in the brain.
• Co-occurring psychiatric disorders are common, and are best treated 
by an integrated, multi-disciplinary approach
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Opioid Addiction and Treatment Information
https://sis.nlm.nih.gov/enviro/addiction.html
https://medlineplus.gov
What if you saw one of these pills on the 
nightstand of your friend or family member?
How do you find out what type of tablet or pill this is? 
https://pillbox.nlm.nih.gov
Use PILLBOX
NLMs Helpful Pill Identification Tool
https://pillbox.nlm.nih.gov
Offering programming on addiction and recovery? Consider 
borrowing one of our Graphic Medicine Book Club Kits featuring 
Sobriety: A Graphic Novel! 
From the publisher… “Through rich 
illustration and narrative, Sobriety: 
A Graphic Novel offers an inside 
look into recovery from the 
perspectives of five Twelve Step 
group members, each with a 
unique set of addictions, 
philosophies, struggles, and 
successes while working the Steps.”
To Request a Kit: www.nnlm.gov/ner/kits
For Questions or Further Information, Contact Matthew 
Noe at Matthew.Noe@umassmed.edu
Use NLM resources for Health & Medical 
Information
• Written by health & medical experts
• Peer-reviewed
• Current
Click on the URL below to get a version 
of this infographic that contains live hyperlinks.
https://infograph.venngage.com/s/Kq2dBc2wdI
Other NLM Online Resources for Trending Health Topics
Questions? 
Comments?
Please use the chat box to ask your questions.
Thank you very much for attending this webinar!
Special thanks to Dr. Amy Harrington for sharing her work with us!
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How to Complete a Course Evaluation and Obtain an MLA CE Credit Certificate
You have 30 days from the date you completed the course to complete an evaluation and claim credit. 
1. Go to www.medlib-ed.org.
2.  Login. If you do not have a current MLANET login, 
please Register as an MLA guest. 
After you’ve set up your MLA account and you're logged in to MLANET, click MEDLIB-ED on the navigation bar to return to MEDLIB-ED.
3. Click My Learning on the blue bar near the top of the MEDLIB-ED home page.
4. Enter the subuse and complete the attestation and evaluation and claim credit.
5. To learn more about MEDLIB-ED, please see the FAQ in the About menu.
6. If you have questions or run into problems, please email MEDLIB-ED@mail.mlahq.org.
